BiotechTube
Home/Co-Diagnostics/Richard S. Serbin
RS

Richard S. Serbin

Chief Financial Officer

Co-Diagnostics

Therapeutic Areas

Infectious Disease

Co-Diagnostics Pipeline

DrugIndicationPhase
Logix Smart COVID-19 TestSARS-CoV-2 InfectionCommercial
Tuberculosis Detection & ResistanceMycobacterium tuberculosisCommercial/Development
Hepatitis B & C TestsHBV/HCV InfectionCommercial/Development
HPV TestHigh-risk Human PapillomavirusCommercial/Development
Malaria TestPlasmodium InfectionCommercial
Zika/Dengue/Chikungunya MultiplexArbovirus InfectionDevelopment
Respiratory Multiplex PanelsInfluenza, RSV, etc.Development

Leadership Team at Co-Diagnostics

DH
Dwight H. Egan
Chief Executive Officer & Director
BL
Brian L. Brown, Ph.D.
Chief Scientific Officer & Director
SE
Seth Egan
Chief Operating Officer
DJ
David J. Politis
Chief Business Officer & Director
View full Co-Diagnostics profile